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5-Fluorouracil (5-FU) has been used for some time for the treat-
ment of malignant disease and mechanism by which the drug is
thought to act is through inhibition of thymidylate synthase (TS).
In addition, several antifolate TS inhibitors have recently been
investigated for their clinical use as chemotherapeutic agents
(Jackman and Judson, 1996). TS is a rate-limiting enzyme
catalysing the reductive methylation of dUMP to dTMP which is
further metabolized to dTTP for DNA synthesis. Inhibition of TS
results in depletion of intracellular dTTP pools and an elevation in
dUMP pools (Jackson et al, 1983; Aherne et al, 1996). In some cell
lines (but not all) expanded dUTP pools are also a consequence of
TS inhibition. 
It is not entirely clear how dNTP perturbations following TS
inhibition result in cell death, but this is often assumed to occur
through uracil misincorporation. When significantly elevated,
dUTP can be misincorporated into DNA in place of dTTP by DNA
polymerase (Brynolf et al, 1978). Incorrectly inserted dUTP
coupled with the action of uracil-DNA glycosylase (UDG) results
in a futile cycle of misrepair leading eventually to DNA strand
breaks and cell death (Goulian et al, 1986). Although this concept
is widely supported by several studies (reviewed in Aherne and
Brown, 1998), dUTP accumulation may not be a critical event
accompanying TS inhibition in all cells. dTTP deprivation itself,
if it occurs for a long enough period of time (greater than a
generation time), induces cell death (Houghton et al, 1994; Matsui
et al, 1996). dATP has also been reported to be elevated following
TS inhibition and it has been proposed that this triggers cellular
events which result in the cleavage of DNA (Chong and Tattersall,
1995; Houghton et al, 1995; Sundseth et al, 1997). 
dNTP perturbations during TS inhibition result in DNA damage
(Curtin et al, 1991; Canman et al, 1994; Matsui et al, 1996), the
response to which may essentially be governed by key down-
stream proteins such as the tumour suppressor p53. Activation of
p53 results in the transactivation of several proteins involved in
G1 cell cycle arrest, apoptosis and DNA repair (O’Connor, 1987;
Zambetti and Levine, 1993). The specific TS inhibitor raltitrexed
(RTX; TomudexTM; ZD1694) has been shown to induce DNA
damage at both the single- and double-stranded level (Yin et al,
1992; Matsui et al, 1996) and p53 has been reported to be respon-
sive to the effects of this drug (Arrendondo et al, 1994). Another
extensively studied function of p53 is as a G1 cell cycle check-
point, where the protein is elevated in response to DNA damage
(Hartwell and Kastan 1994; Nelson and Kastan, 1994). Cell cycle
alterations typical of G1/S phase arrest appear to be a universal
consequence of TS inhibition (Matsui et al, 1996; Tonkinson et al,
1996; Skelton et al, 1998). 
The purpose of this study was to further investigate the
importance of uracil misincorporation in cell death following inhi-
bition of TS. ZD9331 (Jackman et al, 1997) is a specific non-
polyglutamatable antifolate TS inhibitor which is currently being
clinically evaluated. Unlike other TS inhibitors this compound
does not require metabolic activation and the duration of TS inhi-
bition can be more readily controlled. Earlier studies using this
agent have shown that TS activity or protein expression, TS inhi-
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bition as determined by dTTP depletion or intracellular ZD9331
levels could not account for differences in sensitivity between 4
human lung tumour cell lines (Webley et al, 2000). A significant
difference in the extent of dUTP accumulation following ZD9331
was observed. For example in the A549 cell line, increased pools
of dUTP was an early event and over 24 h considerable amounts of
dUTP accumulated. In contrast, in MOR cells dUTP pools were
only marginally increased over those of untreated cells, even when
the dose and duration of drug exposure were increased several-
fold. dUTP accumulation was negatively associated with the
expression of dUTPase, the pyrophosphatase responsible for
maintaining low intracellular levels of dUTP. These results were
consistent with reports on the role of dUTPase in mediating the
effects of TS inhibition (Canman et al, 1993, 1994). In the current
study, the relative roles of dUTP accumulation and dTTP depletion
in cell cycle arrest and cell death following exposure of cells to
ZD9331 in 3 of these cell lines has been addressed. The study has
also briefly assessed the roles of UDG and p53 in downstream
events following TS inhibition. The mutant p53 HT29 human
colon carcinoma cell line transfected with E. coli dUTPase or
vector control (Canman et al, 1994) were used as a paired isogenic
model. 
MATERIALS AND METHODS 
Materials 
All standard laboratory chemicals used in this study were of
AnalaR® grade purchased either from British Drug Houses (BDH)
(Poole, Dorset UK) or from Sigma (Poole, Dorset UK). ZD9331
was synthesized at Zeneca Pharmaceuticals (Macclesfield,
Cheshire, UK), dissolved in 0.15 M sodium bicarbonate (NaHCO3)
(pH 8.3) and filter sterilized. [14C]-thymidine (specific activity 
51.4 Ci mMol–1) and [methyl-3H] thymidine (specific activity 
5.0 Ci mMol–1) were purchased from Amershan International plc. 
Cell culture 
The human lung carcinoma cell lines, A549 (squamous), MOR
(adenocarcinoma) and HX147 (large cell) were maintained at 
37 ˚C in air containing 5% CO2 in DMEM tissue culture medium
(Gibco, Paisley, Scotland) and 10% heat inactivated dialysed 
fetal bovine serum (FBS) supplemented with 2 mM glutamine, 
50 mg ml–1 gentamycin, 2.5 mg ml–1 fungizone, 10 mg ml–1 insulin
and 0.5 mg ml–1 hydrocortisone. The human HT29 colon adenocar-
cinoma  E. coli dUTPase transfected cell line dutE7 and its
neotransfected control CON were kindly provided by Dr Jonathan
Maybaum. These cells were maintained using the above condi-
tions. All cells were free of mycoplasma during experimentation.
Growth inhibition was measured using MTT assay as previously
described (Webley et al, 2000). 
Flow cytometry 
Following ZD9331 treatment (1 mM for 4 or 24 h), adherent cells
(1 ´ 106) were harvested by gentle scraping in 10 ml of ice cold
PBS and pelleted by refrigerated centrifugation for 5 min at 
2500 rpm (600 g). Cell pellets were resuspended in 200 ml PBS
and 2 ml of ice-cold 70% ethanol was added to the cell suspen-
sion (whilst being vortexed) and left for at least 30 min at 4˚C.
The cells were centrifuged at 2500 rpm (600 g) for 5 min (4˚C),
resuspended in 800 ml of PBS into which 100 ml RNase 
(1 mg ml–1) and 100 ml propidium iodide (400 mg ml–1) were
added. After a 30 min incubation period at 37˚C, cell cycle
analysis was performed using an argon-ion laser (Coulter Ltd,
Luton UK) operated at 488 nm. Following pulse shape analysis
and gating on a cytogram of orthogonal vs forward light scatter, a
DNA histogram of cell number against red (DNA-PI) fluores-
cence was recorded. 
Colony-forming assays 
Cells were plated in a T-25 tissue culture flask (2 ´ 105 cells/5 ml)
and exposed to ZD9331 1 mM) once exponential growth had been
reached. After 4, 24 or 48 h drug exposure, cells were harvested
using cell dissociation solution (Sigma) and suspended in 8.5 ml
of culture medium containing non-dialysed FBS. After centrifuga-
tion at 1500 rpm (300 g) for 5 min (room temperature), cells were
resuspended in 2 ml of the same medium and then diluted to
between 400–1000 cells/10 ml and plated onto 10 cm Petri dishes.
The cells were left to form colonies for 14 days, after which the
colonies were stained with 0.2% crystal violet in PBS containing
10% formalin and those with greater than 50 cells counted. The
average plating efficiency for each cell line was approximately
40%. The loss of colony formation was expressed as the
percentage plating efficiency of the test cells compared to the
plating efficiency of the control cells. 
Measurement of DNA damage by alkaline elution 
The method used to measure DNA single-strand breaks following
TS inhibition has been described previously (Curtin et al, 1991).
Irradiated internal standard cells were co-eluted with experimental
cells to allow standardization of elution rate. For studies
measuring mature DNA damage, experimental cells were incu-
bated with 0.4 mCi [14C] Thd and internal standards were incu-
bated with 1 mCi [methyl-3H] Thd for 24 h. After a 4–24 h post-
labelling chase period in fresh medium, the medium was replaced
with ZD9331-containing medium for 4, 24 or 48 h. For measure-
ments of nascent DNA damage, radiolabelled Thd was present for
only the last 4 h of drug treatment prior to harvesting. For quanti-
tation, the retention of sample cell DNA (14C) was evaluated at the
point when the retention of internal standard (3H) was 0.5. The rad
equivalents were determined in each experiment as previously
described (Kohn, 1981). 
UDG assay 
5 ´ 105 cells were lysed (50 mM Tris-HCl (pH 7.4), 0.25 M NaCl,
0.1% NP40, 50 mM NaF and 5 mM EDTA) frozen at –80˚C,
thawed, and sonicated twice for 30 s (10 amplitude microns,
Soniprep 150 MSE). Following centrifugation at 9000 g for 
10 min at 4˚C the supernatant was used to determine UDG
activity. The UDG assay (Caradonna and Cheng, 1980) is based on
the release of 3H-uracil from a [3H] uracil-containing calf thymus
DNA preparation that was kindly prepared by Dr Salvatore
Caradonna. The assay was performed using the procedures
described previously (Muller-Weeks and Caradonna, 1996).
Briefly, reactions took place at 37˚C in a volume of 100 ml
containing 45 ml 100 mM Tris HCI pH 7.5, 4 mM DTT, 10 mM
EDTA, 0.2 mg ml–1 BSA, 2 ml calf thymus [3H]uracil-DNA
substrate (8.35 nmoles ml–1) and 3 ml water. The reaction was448 SD Webley et al 
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initiated by the addition of 50 ml of diluted cell extract and left for
5 to 10 min. 25 ml of salmon sperm (DNA 1 mg ml–1) (Sigma) and
25 ml 4M PCA were used to terminate the reaction. After 10 min
on ice, the samples were centrifuged at 18 000 rpm (9000 g) in a
Micro Centaur (MSE) centrifuge for 10 min and the amount of
radioactivity in the supernatant counted. A unit of UDG activity
was expressed as the amount of glycosylase required to release 
1 pmol of uracil min–1 mg–1 of protein at 37˚C. 
Western immunoblot analysis 
Following exposure of 1 ´ 106 cells to 1 mM ZD9331 for 4, 24 or
48 h, Western blot analysis was performed according to standard
protocol, and the protein bands of interest were probed using either
a mouse monoclonal antibody to p53 (D01) (Autogen Bioclear,
UK, Calne, Wiltshire) or p21 (Santa Cruz, clone 19). The expres-
sion of tubulin was also determined using a mouse monoclonal
anti-a-tubulin (Clone B-5-1-2, Sigma) to provide evidence of
equal protein loading. In irradiation studies, cells were exposed to
5 Gy delivered using a 137Cs source-to-flask distance of 40 cm and
a dose rate of 1.36 Gy min–1 then left for 4 h before harvesting.
Visualization of the protein bands of interest was performed 
using enhanced chemiluminescence (ECL) reagents (Amersham
International). 
Protein estimation 
Protein concentrations were measured in cell lysates using the
BCA assay (Perbio) according to the manufacturer’s instructions. 
RESULTS 
Changes in the cell cycle following ZD9331 
Representative DNA histograms generated following ZD9331
(1 mM) treatment of A549, HX147 and MOR cells for 4 and 24 h
are shown in Figure 1. Prior to ZD9331 exposure, all cell lines
showed a cell cycle profile typical of cells in log phase growth,
with most cells in G1 and the remaining cells distributed between
S and G2/M. A 4 h exposure to ZD9331 resulted in the disappear-
ance of a discernible G2/M peak in all cell lines. A longer drug
exposure (24 h) caused an increase in the percentage of cells in G1
and a decrease in the percentage of cells in S phase. In A549 cells,
there was evidence of a sub G1 peak that may represent cell debris
following a 24 h exposure to ZD9331. By 48 h, this peak had
broadened and a sub-G1 peak was clearly discernible (data not
shown). Profiles of this type result from the presence of apoptotic
cells (Darzynkiewicz et al, 1992). 
Reversal of ZD9331 cell cycle effects following 
re-suspension in DFM 
The HT29 dutE7 and CON cell lines showed similar cell cycle
profiles following a 24 h exposure to 1 mM ZD9331 i.e. loss in the
G2/M peak (Figure 1). To establish whether the drug-treated cells
retain their ability to synthesize DNA and re-enter the G2/M phase
once extracellular drug is removed, dutE7 and CON cells were
treated with 1 mM ZD9331 (24 h) and then resuspended in non-dial-
ysed DFM for a further 24 h before cell cycle analysis. Once the drug
was removed from the medium, the G2/M peak in both cell lines re-
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Figure 1 DNA histograms of cell cycle changes following 1 mM ZD9331 in A549 (A), HX147 (B) and MOR (C) cells at 0, 4 and 24 h after ZD9331 (1 mM) and
in CON (D) and dutE7 (E) cells 0 h and 24 h after ZD9331 (1 mM) and after a further 24 h period in drug-free medium (DFM). At the indicated times after dosing,
cells were fixed with 70% ethanol and stained with propidium iodide as described in the Materials and Methods. Histograms are representative of the results of
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emerged indicating that some cells at this point were capable of
leaving S phase and could re-enter the G2/M phase of the cell cycle. 
ZD9331 induced cytotoxicity 
The 24 h growth inhibitory IC50 concentrations previously deter-
mined by MTT assay for these cell lines were 0.11, 0.17 and 
0.28 mM for A549, HX147 and MOR respectively (Webley et al,
2000). A 4 h exposure to ZD9331 (1 mM) had no effect on
viability in any of the cell lines. However, by 24 h, A549 cells
showed a significant (P < 0.0001) loss of viability (7.7% of
control) which was further reduced to 0.96% of control after 48 h
in drug (Figure 2). The viability of HX147 cells was also signifi-
cantly reduced to 36.5 and 2.9% survival at 24 h (P = 0.01) and 48
h (P < 0.001) respectively. In contrast, MOR cells were more resis-
tant to the cytotoxic effect of ZD9331 at 24 h compared to both
HX147 and A549 cells, and did not begin to significantly lose the
ability to form colonies until 24–48 h in drug (P < 0.0001). Indeed
MOR cells were significantly (P < 0.05) more resistant to a 24 h
exposure to ZD9331 than A549 cells. 
The 24 h growth inhibition IC50 concentrations determined by
MTT assay for CON and dutE7 were 0.22 mM ± 0.05 and 15.6 mM
± 3 respectively. The 120 h IC50 values were 0.04 mM ± 0.01 and
0.152 mM ± 0.04 for CON and dutE7 respectively (Brown et al,
1997). By 24 h ZD9331 was significantly more cytotoxic in the
neotransfected controls than in the dUTPase transfected cells
(Figure 3). By 48 h however both cell lines showed a similar loss
of viability (1.27% and 5.3% for CON and E7 cells respectively)
although the protective effect of dUTPase was still evident. 
Effect of ZD9331 on DNA integrity 
Nascent DNA 
A 4 h exposure to ZD9331 (1 mM) caused no measurable effect on
nascent DNA in A549 cells but by 24 h substantial DNA damage
was measured (Table 1). In contrast, MOR cells showed an earlier
and greater amount of damage to nascent DNA. HX147 cells
showed a similar pattern of DNA damage in response to ZD9331
as A549 cells. 
Mature DNA 
In A549 cells no damage to mature DNA was measured following
a 4 h exposure to ZD9331. However by 24 h, damage to mature
DNA was substantial (471 ± 95 rad equivalents) (Table 1). In
contrast 3–4-fold less damage was observed in MOR cells
following a 24 h exposure to ZD9331. A 48 h exposure to drug
resulted in a similar extent of damage to mature DNA in A549 and
MOR cells. HX147 cells had less mature DNA damage compared
to A549 cells. 
Uracil DNA glycosylase (UDG) activity 
A549 cells had significantly (P > 0.05) higher UDG activity 
(932 ± 248 pmole uracil min–1 mg–1) compared to MOR and
HX147 cells (201 ± 30.6 and 166.9 ± 16.4 pmole uracil min–1 mg–1
respectively) (Figure 4). UDG activities in CON and dutE7 were
not significantly different (404 ± 88 and 454 ± 238 pmole uracil
min–1 mg–1 respectively). 
Table 1 Nascent and mature DNA damage rad equivalents. 
Nascent DNA damage 
A549 MOR HX147 
4 h 0 117 ± 5.4 0 
24 h 264 ± 9.8 500: 608 134 ± 153.4 
Mature DNA damage 
A549 MOR HX147 
4 h 0 0 ND 
24 h 471 ± 95 134 ± 28 153 ± 21 
48 h 268: 279 281: 295 ND 
Data represents the mean of 2–3 experiments conducted in duplicate (± SD).
ND=not determined. 
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Figure 2 Effect of ZD9331 on colony formation in 3 human lung tumour cell
lines. Cells were treated with 1 mM ZD9331 for the indicated times before
plating out in DFM. The data represents the results of 3 experiments carried
out in duplicate. Bars represent SD.*** and ** denotes a significant 
(P < 0.0001 and P < 0.01 respectively) loss of viability 
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Figure 3 Effect of ZD9331 on colony formation in HT29 dutE7 and CON
cell lines. Cells were treated with 1 mM ZD9331 for the indicated times before
plating out in DFM. The data represents the results of 3 experiments carried
out in duplicate. Bars represent SD. *** and ** denotes a significant 
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Changes in the expression of p53 and p21 following
exposure to ZD9331 
Using Western blot analysis, levels of p53 were undetectable in
all 3 untreated human tumour cell lines. The functional p53 status
in these cell lines was confirmed by irradiation. Following irradi-
ation (5 Gy), only A549 cells showed increased p53 expression.
Low expression of p21 protein was detected in A549 control cells
and was markedly elevated following irradiation. However, p21
was not detectable in either MOR or HX147 before or after irradi-
ation (Figure 5A). Treatment with ZD9331 caused a time-related
increase in p53 protein in A549 cells; p53 was clearly detected by
24 h and rose considerably by 48 h (Figure 5B). Expression of
p21 was also increased in response to ZD9331. These proteins
were not detected in MOR or HX147 cells following ZD9331
exposure. 
DISCUSSION 
The main aim of this study was to further investigate the relative
roles of dTTP and uracil misincorporation in cellular sensitivity to
TS inhibition. 3 human tumour cell lines and a pair of isogenic cell
lines differing only in the expression of dUTPase have been used.
Against a background of dTTP depletion (>80% compared to
untreated controls), A549, HX147 and MOR cells accumulate
markedly different amounts of dUTP (57, 17 and 1.2 pmole/106
cells respectively) following a 24 h exposure to 1 mM ZD9331
(Webley et al, 2000). A longer duration of exposure to the drug
served to further expand the dUTP pools in A549 and HX147 cells
but had little effect on MOR cells. This difference in dUTP
accumulation broadly related to dUTPase activity and protein
expression. The cell lines also displayed differences in sensitivity
to the growth inhibitory effects of ZD9331 depending on the dura-
tion of exposure; A549 cells were equally sensitive to a short and
long exposure, whereas MOR and HX147 cells were more sensi-
tive to a long drug exposure. The current study has addressed
whether the extent of dUTP accumulated is related to changes in
the cell cycle, loss of viability and DNA damage following treat-
ment with ZD9331. In addition, the roles of p53 and p21 in medi-
ating cell cycle and cytotoxic events following TS inhibition have
also been addressed. 
The viability of the cell lines after ZD9331 exposure depended
on the duration of exposure; A549 cells showed an earlier (24 h)
cytotoxic response compared to MOR cells which did not signifi-
cantly lose clonogenicity until 48 h. ZD9331 was less cytotoxic to
HX147 cells than A549 cells. A direct association therefore exists
between the amount of dUTP formed and the time required to
significantly lose viability. This observation is similar to that
previously reported with fluoropyrimidines (Canman et al, 1993).
Following exposure to FdUrd, loss of viability was later (24–32
h) in SW620 cells which accumulated low levels of dUTP than in
HT29 cells (10–16 h) that accumulated 45-fold more dUTP. The
neotransfected HT29 cells (CON) (mutant p53) accumulate a
similar level of dUTP as A549 cells (wild-type p53) following
exposure to ZD9331 (Brown et al, 1997). The former also showed
an early loss in clonogenicity compared to the dUTPase trans-
fected dutE7 HT29 cell line although this difference was lost at
later time points. This observation has been reported with other
TS inhibitors (Canman et al, 1994; Parsels et al, 1998). In addi-
tion, a greater difference in the level of growth inhibition was
observed between CON and dutE7 at 24 h (71 fold), than at 120 h
(3.8 fold). Therefore, against the same genetic background,
reduced dUTP pools (and presumably DNA damage) can
decrease the cytotoxic response to TS inhibition but this effect is
largely time dependent. 
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Figure 4 UDG activity. Cells in exponential growth were harvested and
assayed for UDG activity as detailed in Materials and Methods. UDG activity
is expressed as pmole uracil released min–1 mg–1 protein. The data
represents the results of 3–4 experiments carried out in duplicate. Bars
represent SD. * denotes a significantly (P < 0.05) higher UDG activity in A549
cells than MOR and HX147 cells 
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Alterations in the cell cycle in response to antifolates such as
methotrexate (Taylor et al, 1982; Savage and Prasad, 1988) RTX
(Matsui et al, 1996; Tonkinson et al, 1997) and other TS inhibitors
(Skelton et al, 1998) have previously been reported. The cell cycle
effects of TS inhibition (S-phase arrest resulting in reduced
numbers of cells in G2/M and increased numbers of cells in G1)
appears to be a universal consequence of TS inhibition and also
occur following ZD9331 exposure. The cell cycle pattern typical of
TS inhibition was observed by 4 h following drug treatment in all
the cell lines studied. Thus in contrast to cytotoxicity, cell cycle
arrest does not appear to depend on variations in dUTP accumula-
tion (or as discussed later, p53 function). Also, the differential cyto-
toxicity observed is occurring during a cell cycle arrested state. 
Re-suspension of ZD9331-treated cells (HT29 CON and dutE7)
in drug-free medium restored normal S phase progression for up to
24 h at least in some cells. Thus arrest at the G1/S border may be a
consequence of incomplete DNA synthesis due to reduced dTTP
pools and not the irreversible inactivation of the DNA synthesis
machinery. The RTX induced S-phase arrest in HCT-8 and SW620
cells was also shown to be due to the block in DNA synthesis as
result of dTTP depletion (Matsui et al, 1996) and the addition of
exogenous thymidine to the arrested cells restored normal S-phase
progress. 
The formation of DNA single strand breaks has widely been
reported following treatment with TS inhibitors (Curtin et al,
1991; Yin et al, 1992; Canman et al, 1993). Nascent DNA damage
in response to ZD9331 was observed in MOR cells as early as 4 h
and by 24 h a significant extent of damage was measured. In
contrast, A549 cells were less sensitive to this type of damage.
However, cytotoxicity in MOR cells was significantly less than in
A549 cells although it is thought that the inhibition of nascent
DNA synthesis for an extended period of time would eventually
result in commitment to cell death (Houghton et al, 1994). 
It is known that cells in S-phase are most sensitive to the effects
of TS inhibitors (Tang et al, 1996) and it is not clear why a larger
degree of nascent DNA damage was not found in the A549 cell
line. More damage of this nature may have been expected since
dTTP pools were depleted (> 80%) to the same extent as in the
other cell lines (Webley et al, 2000), and because of the large accu-
mulation of dUTP that occurs following ZD9331 treatment.
Damage to mature DNA is believed to reflect the inability to repair
spontaneously occurring damage and in this context, may reflect
the effect of the misincorporation process. 
The presence of mature DNA single strand breaks is consistent
with the corresponding loss of viability following treatment with
ZD9331. Previous work found that the extent of mature DNA
damage in HT29 and SW620 was proportional to the intracellular
dUTP accumulated in these cells following FdUrd exposure
(Canman et al, 1993). The extent of dUTP accumulation has also
been shown to correlate with the extent of DNA damage (Curtin 
et al, 1991). It has been demonstrated that by transfecting HT29
cells with the antisense-expressing construct of the DUT-N open
reading frame, dUTP accumulation and DNA damage can be
increased (Ladner and Caradonna, 1997). As expected from the
large difference in dUTP accumulation, A549 cells had higher
levels of mature DNA damage than MOR and HX147 cells. UDG
is a repair enzyme that rapidly removes misincorporated uracil
from DNA creating alkaline labile apyrimidinic sites. The signifi-
cantly (P < 0.05) higher UDG activity in A549 cells compared to
HX147 cells, may have also contributed to the formation of mature
DNA damage. 
The similarity between the 24 and 120 h IC50 concentrations for
ZD9331 in A549 cells (Webley et al, 2000) suggests that these
cells are largely committed to cell death within 24 h of drug expo-
sure. This may be due to dUTP accumulation and the level of
mature DNA damage that occur during the first 24 h exposure to
ZD9331. Following a 48 h exposure to ZD9331 DNA damage was
reduced, presumably because of cell loss due to apoptosis. MOR
cells required a longer period of exposure to ZD9331 to show
significant mature DNA strand breaks (compared to A459 cells).
Other studies, using cells that do not accumulate dUTP during a
thymineless state, have noted that the appearance of significant
damage to mature DNA is a late event occurring between 24 and
48 h (Houghton et al, 1994; Sundseth et al, 1997). 
Exposure of A549, MOR and HX147 cell lines to radiation
confirmed that only the A549 cells have functional p53 and it was
therefore not surprising that only A549 cells showed an elevation
in p53 following ZD9331. However, all cell lines displayed an
obvious G1/S arrest after only a 4 h exposure to ZD9331. In addi-
tion, this arrest occurred before the large rise in p53 protein
expression in A549 cells. The same cell cycle effects following
ZD9331 were observed in the p53-mutant HT29 dUTPase trans-
fected cell line (dutE7) and its neotransfected control. p53 has
been reported to play a passive role in RTX-induced cell cycle
perturbation in HCT-8 (wt53) and SW480 (mutant p53) (Matsui 
et al, 1996). 
Cellular response to TS inhibitors is complex but is probably
mediated through a combination of both dTTP depletion and uracil
misincorporation. It is difficult to evaluate the relative importance
of these concurrent effects as dUTP accumulation will occur (to
different extents) only in the presence of dTTP depletion. The
expression of enzymes such as dUTPase, repair enzymes such as
UDG and downstream factors (Fisher et al, 1993) are also impor-
tant factors. Nevertheless, these studies have confirmed that the
cell cycle events that are typical of TS inhibition occur regardless
of p53 function and are independent of dUTP accumulation.
However, there is an association between early cytotoxicity to TS
inhibitors and the extent of dUTP accumulation. Importantly, in
some cell lines, (e.g. MOR) the mechanism of cell death following
TS inhibition is dUTP independent confirming the importance of
dTTP depletion and other dNTP perturbations to the process of
eventual cell death. It could be argued that the early loss of
viability observed in the high dUTP accumulating A549 cell line,
is due to the presence of functional p53 rather than uracil misin-
corporation per se. However, in the p53 mutant HT29 cell line
high accumulation of dUTP appears to confer early cytotoxicity
compared to a dUTPase expressing transfect. The use of paired
cell lines with known p53 function (e.g. transfected with p53
inducible constructs or p53 ‘knockouts’) would provide further
insight into the relative roles of dUTPase and p53 in promoting
cell death in TS inhibited cells. In addition, high UDG activity in
cell lines that accumulate dUTP may exacerbate the effects of TS
inhibitors thereby promoting DNA damage. The therapeutic
importance of dUTPase and UDG expression in relation to p53
status remains to be determined and further studies using appropri-
ately transfected (dUTPase and UDG) cell lines are warranted. 
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